Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.70 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.61 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.61 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.61 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.59 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.59 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12924873 | 0.84 | KMT2A (0.72) | KMT2ACHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL17915488 | 0.83 | KMT2A (0.70) | KMT2ACHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL11329318 | 0.83 | KMT2A (0.70) | KMT2ACHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL5522307 | 0.82 | KMT2A (0.81) | KMT2ACYP2D6MEN1PTGS1PTGS2 | |
| SCHEMBL5514748 | 0.82 | KMT2A (0.81) | KMT2ACYP2D6MEN1PTGS1PTGS2 | |
| SCHEMBL23872457 | 0.82 | CYP2D6 (0.61) | KMT2ACHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL4921518 | 0.82 | CYP2D6 (0.61) | KMT2ACHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL499471 | 0.82 | CYP2D6 (0.61) | KMT2ACHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL1578725 | 0.82 | KMT2A (0.81) | KMT2ACYP2D6MEN1PTGS1PTGS2 | |
| SCHEMBL12924861 | 0.80 | KMT2A (0.78) | KMT2ACYP2D6MEN1PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110009617-A1 | Ruthenium Catalysts and Uses Thereof | CHE CHI-MING | 2011-01-13 | — | — | US | disclosed |
| US-20080207476-A1 | PARTICLES CONTAINING PERFUME HAVING IMPROVED FRAGRANCE PROPERTIES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009617-A1 | Ruthenium Catalysts and Uses Thereof | CYCS, POR, CPNE4 | KMT2A 2447/4885CHRM2 1132/4885CHRM4 1165/4885 |
| US-20080207476-A1 | PARTICLES CONTAINING PERFUME HAVING IMPROVED FRAGRANCE PROPERTIES | DSC1, DSG1, PIEZO1 | KMT2A 3381/4885CHRM2 2223/4885CHRM4 1905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.